Literature DB >> 1924388

Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype.

D Polsky1, F Lilly.   

Abstract

Mice homozygous for the H-2d haplotype at the major histocompatibility complex are markedly more susceptible to erythroleukemia induction by the Friend isolate of murine leukemia retrovirus (FV) than are congenic mice homozygous for the H-2b haplotype. The resistance conferred by the H-2b haplotype is recessive in this cross, since heterozygous F1 mice are as susceptible as parental strain H-2d homozygotes. However, H-2b-associated resistance is not an intrinsically recessive trait, since H-2b/H-2dm1 heterozygotes resemble H-2b homozygotes in their relative resistance to FV; the mutant H-2dm1 haplotype lacks the entire D region of the parental haplotype except for a single class I gene formed by the fusion of its terminal D-region genes to produce a class I gene differing from both parental genes, and thus this finding indicates that one or more D-region genes of the H-2d haplotype can actively suppress H-2b-associated resistance. Unlike H-2dm1, the mutant H-2dm2 haplotype, which retains only the class IDd gene in the D region of the H-2d haplotype, strongly suppresses resistance in H-2b/H-2dm2 heterozygotes, and the presence of Dd as a transgene significantly reduces the resistance of H-2b homozygotes. Since H-2b-associated resistance to FV appears to be due mainly to the capacity of Lb (also called Db), the only class I molecule encoded in the D region of the H-2b haplotype, to present viral epitopes for recognition by FV-specific cytotoxic T lymphocytes, suppression of resistance to FV by the Dd molecule implies that the presence of one class I molecule of the major histocompatibility complex can interfere with either the presentation of viral epitopes by another class I molecule or the generation of T cells that recognize viral epitopes so presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924388      PMCID: PMC52690          DOI: 10.1073/pnas.88.20.9243

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Ir-LDHB: map position and functional analysis.

Authors:  I Melchers; K Rajewsky; D C Shreffler
Journal:  Eur J Immunol       Date:  1973-12       Impact factor: 5.532

2.  Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice.

Authors:  F Lilly
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

Review 3.  Biology and genetics of hybrid resistance.

Authors:  M Bennett
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

4.  Regulated expression of a murine class I gene in transgenic mice.

Authors:  C Bieberich; G Scangos; K Tanaka; G Jay
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

5.  Mutation in a new H-2-associated histocompatibility gene closely linked to H-2D.

Authors:  T H Hansen; S E Cullen; R Melvold; H Kohn; L Flaherty; D H Sachs
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

6.  Organization and evolution of D region class I genes in the mouse major histocompatibility complex.

Authors:  D Stephan; H Sun; K F Lindahl; E Meyer; G Hämmerling; L Hood; M Steinmetz
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

7.  Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.

Authors:  C A Holt; K Osorio; F Lilly
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

8.  Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.

Authors:  B Chesebro; K Wehrly; J Stimpfling
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

9.  Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice.

Authors:  G Cudkowicz; M Bennett
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

10.  Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice.

Authors:  H O McDevitt; M Sela
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  6 in total

1.  Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice.

Authors:  K J Hasenkrug
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

3.  Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus.

Authors:  K S Ruan; F Lilly
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

4.  Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.

Authors:  U Dittmer; D M Brooks; K J Hasenkrug
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

5.  Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice.

Authors:  K J Hasenkrug; D M Brooks; U Dittmer
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

6.  Recovery from Friend disease in mice with reduced major histocompatibility complex class I expression.

Authors:  K J Hasenkrug; G J Sprangrude; J Nishio; D M Brooks; B Chesebro
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.